Polymeric Nanoparticles Market Statistics - 2030

The polymeric nanoparticles market was valued at $551.9 million in 2020, and is projected to reach $1,511.8 million by 2030, growing at a CAGR of 10.6% from 2021 to 2030.

[COVIDIMPACTSTATEMENT]

Polymeric nanoparticles are organic nanoparticles. It has the size array from 1 to 1000 nm. Polymeric nanoparticles can be filled with active compounds entrapped inside or surface-adsorbed onto the polymeric nucleus. It has received significant traction within the pharmaceutical industry. It is utilized for controlled drug release and targeted drug delivery. Degradation time is one of the most significant characteristics of drug delivery vehicles.

Get more information on this report : Request Sample Pages

The drug delivery industry is driven by factors such as increase in number of developments made by key industrial participants in drug delivery system, increase in prevalence of chronic disorders which needs the utilization of drug delivery systems, and surge in healthcare expenditure globally. Furthermore, the polymeric nanoparticles market is also driven by rapidly growing electronics industry in developing economies such as India. However, the polymeric nanoparticles market is hindered by the factors such as high prices and complex production process. On the contrary, the increase in study of polymeric nanoparticles in vaccines is expected to offer lucrative opportunity during the forecast period.

The polymeric nanoparticles market is segmented on the basis of type, end-use industry, and region. On the basis of type, the polymeric nanoparticles market is bifurcated into nanocapsule and nanosphere. On the basis of end-use industry, the market is segregated into pharmaceutical, electronics, and others. Others segment comprise nutraceuticals industry, academic research, biomedical (biosensor), coatings, catalysts etc. Region-wise, the polymeric nanoparticles market share is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The polymeric nanoparticles market share is analyzed across all segments.

The polymeric nanoparticles market analysis covers in-depth information of the major industry participants. Some of the major players in the polymeric nanoparticles market include Aphios Corporation (Aphios), Nano research elements (Nanorh), Phosphorex, Inc. (Phosphorex), CD Bioparticles (CD Bioparticles), NanoSynthons LLC (NanoSynthons), Biopharma PEG (Biopharma), Creative PEGWorks (CPW), Nanoshel, Exelead, and Nanovex Biotechnologies SL (Nanovex).

Other players in the value chain of the polymeric nanoparticles market include Thermo scientific (Thermo), Dolomite Microfluidics (Dolomite), Evonik, Advanced Nanotech Lab. (Advanced Nanotech), Sintef, Merckmillipore (Merck), HiQ-Nano s.r.l. (HiQ-Nano), Attonuclei, and others.

The key players are adopting numerous strategies such as partnership, agreement, collaboration, joint venture to stay competitive in the polymeric nanoparticles market.

For instance, in June 2021, Phosphorex and Dolomite Microfluidics inked a partnership to combine their capabilities in vaccine and drug development. The aim of the partnership is to develop lipid nanoparticle and polymeric nanoparticle. Polymeric nanoparticles, lipid nanoparticles, and liposomes are utilized as tools for non-viral delivery of therapeutics, especially nucleic acids, comprising mRNAs for vaccines to fight cancer and dangerous diseases such as COVID-19. These nanoparticles can improve stability, transfection efficiency, efficacy, and safety of RNA therapeutics and vaccines. Dolomite’s ANP System is planned to improve Phosphorex’s service offering, including optimization, development of prototype formulations, and others.

Polymeric Nanoparticles Market, by Type

By type, the nanosphere segment garnered 75.1% in 2020, in terms of revenue and expected to grow at a CAGR of 10.5%. Nanospheres have a lot of potential since they can turn poorly soluble, poorly absorbed medicines into more easily delivered medications. Nanospheres are site-specific and protect the medicine from various bodily fluids that could destroy it during targeting. These factors are projected to boost the demand for nanosphere. Furthermore. the nanocapsule segment is expected to grow at a CAGR of 10.8%.

[TYPEGRAPH]

Get more information on this report : Request Sample Pages

Polymeric Nanoparticles Market, by End-use industry

By end-use industry, the pharmaceutical segment garnered market share of 10.6% in 2020, in terms of revenue. This is attributed to rise in awareness regarding the utilization of pharmaceutical drug delivery products. The constantly evolving life science industry propels the market growth as constant developments lead to increased awareness related to the utilization of pharmaceutical drug delivery.

[ENDUSEINDUSTRYGRAPH]

Get more information on this report : Request Sample Pages

Polymeric Nanoparticles Market, by Region

Region-wise, Asia-Pacific is expected to grow at a CAGR of 11.4%, during the forecast period. U.S. has the largest share in the pharmaceutical industry but China is growing at a considerable rate. Furthermore, India is also the one of the huge and fastest growing pharmaceutical industry.

[REGIONGRAPH]

Get more information on this report : Request Sample Pages

Key benefits for stakeholders

• The report outlines the current polymeric nanoparticles market trends and future scenario of the market from 2021 to 2030 to understand the prevailing opportunities and potential investment pockets.
• The polymeric nanoparticles market size is provided in terms of revenue.
• The report provides an in-depth analysis of the market along with the current and future market trends.
• This report highlights the key drivers, opportunities, and restraints of the polymeric nanoparticles market along with impact analysis during the forecast period.
• The report also covers the impact of governmental regulations on the polymeric nanoparticles market.
• Porter’s five forces analysis helps analyze the potential of buyers & suppliers and the competitive scenario of the industry for strategy building.
• The study provides a comprehensive analysis of the factors that drive and restrain the polymeric nanoparticles market growth.

Impact of COVID-19 on the Polymeric Nanoparticles market

• The outbreak of COVID-19 has increased the research studies for treating COVID-19 by nanoparticles. Since the pandemic has begun, the field of nanomedicine has been analyzing nanoparticles as a hopeful method to cure infected patients.
• The nanoparticles can be developed into smart means to transfer drugs to particular tissues while refraining the drug-related toxicity.
•  A variety of nanomaterials, comprising polymeric nanoparticles, metallic nanoparticles, etc., are already utilized for virus detection.
• The choice of polymer-based nanoparticles provides drug stability with smart release characteristics while successfully transferring drugs straight to the targeted site

Key Market Segments

By Type

• Nanocapsule
• Nanosphere

By End-use industry

• Pharmaceutical
• Electronics
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

 Key Market Segments

• By TYPE
  • Nanocapsule
  • Nanosphere
• By END-USE INDUSTRY
  • Pharmaceutical
  • Electronics
  • Others
• By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
    • Malaysia
    • Indonesia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • UAE
    • Argentina
    • Rest of LAMEA

 
Key Market Players

• Nanoshel
• NanoSynthons LLC
• Phosphorex, Inc.
• CD Bioparticles
• Nanovex Biotechnologies SL
• Aphios Corporation
• Nanorh
• Exelead
• Creative PEGWorks
• Biopharma PEG

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.Key findings

2.2.1.Top investment pockets

2.3.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Porter's five forces analysis
3.3.Market dynamics

3.3.1.Drivers

3.3.1.1.Increased demand from pharmaceutical industry
3.3.1.2.Increased demand from automotive industry

3.3.2.Restraint

3.3.2.1.Complex manufacturing process

3.3.3.Opportunity

3.3.3.1.Increasing preference for polymeric nanoparticles in electronics manufacturing

3.4.Impact of COVID-19 outbreak on the polymeric nanoparticles market

CHAPTER 4:POLYMERIC NANOPARTICLES MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Nanocapsule

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Nanosphere

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

CHAPTER 5:POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY

5.1.Overview

5.1.1.Market size and forecast

5.2.Pharmaceutical

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Electronics

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

5.4.Others

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country

CHAPTER 6:POLYMERIC NANOPARTICLES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by type
6.2.3.Market size and forecast, by end-use industry
6.2.4.Market size and forecast, by country

6.2.4.1.U.S.

6.2.4.1.1.Market size and forecast, by type
6.2.4.1.2.Market size and forecast, by end-use industry

6.2.4.2.Canada

6.2.4.2.1.Market size and forecast, by type
6.2.4.2.2.Market size and forecast, by end-use industry

6.2.4.3.Mexico

6.2.4.3.1.Market size and forecast, by type
6.2.4.3.2.Market size and forecast, by end-use industry

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by type
6.3.3.Market size and forecast, by end-use industry
6.3.4.Market size and forecast, by country

6.3.4.1.Germany

6.3.4.1.1.Market size and forecast, by type
6.3.4.1.2.Market size and forecast, by end-use industry

6.3.4.2.France

6.3.4.2.1.Market size and forecast, by type
6.3.4.2.2.Market size and forecast, by end-use industry

6.3.4.3.UK

6.3.4.3.1.Market size and forecast, by type
6.3.4.3.2.Market size and forecast, by end-use industry

6.3.4.4.Italy

6.3.4.4.1.Market size and forecast, by type
6.3.4.4.2.Market size and forecast, by end-use industry

6.3.4.5.Spain

6.3.4.5.1.Market size and forecast, by type
6.3.4.5.2.Market size and forecast, by end-use industry

6.3.4.6.Rest of Europe

6.3.4.6.1.Market size and forecast, by type
6.3.4.6.2.Market size and forecast, by end-use industry

6.4.Asia-Pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by type
6.4.3.Market size and forecast, by end-use industry
6.4.4.Market size and forecast, by country

6.4.4.1.China

6.4.4.1.1.Market size and forecast, by type
6.4.4.1.2.Market size and forecast, by end-use industry

6.4.4.2.Japan

6.4.4.2.1.Market size and forecast, by type
6.4.4.2.2.Market size and forecast, by end-use industry

6.4.4.3.India

6.4.4.3.1.Market size and forecast, by type
6.4.4.3.2.Market size and forecast, by end-use industry

6.4.4.4.South Korea

6.4.4.4.1.Market size and forecast, by type
6.4.4.4.2.Market size and forecast, by end-use industry

6.4.4.5.Australia

6.4.4.5.1.Market size and forecast, by type
6.4.4.5.2.Market size and forecast, by end-use industry

6.4.4.6.Rest of Asia-Pacific

6.4.4.6.1.Market size and forecast, by type
6.4.4.6.2.Market size and forecast, by end-use industry

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by type
6.5.3.Market size and forecast, by end-use industry
6.5.4.Market size and forecast, by country

6.5.4.1.Brazil

6.5.4.1.1.Market size and forecast, by type
6.5.4.1.2.Market size and forecast, by end-use industry

6.5.4.2.Saudi Arabia

6.5.4.2.1.Market size and forecast, by type
6.5.4.2.2.Market size and forecast, by end-use industry

6.5.4.3.South Africa

6.5.4.3.1.Market size and forecast, by type
6.5.4.3.2.Market size and forecast, by end-use industry

6.5.4.4.Rest of LAMEA

6.5.4.4.1.Market size and forecast, by type
6.5.4.4.2.Market size and forecast, by end-use industry

CHAPTER 7:COMPETITIVE LANDSCAPE

7.1.Introduction

7.1.1.Market player positioning, 2020

7.2.Product mapping
7.3.Key developments
7.3.1.Partnership

CHAPTER 8:COMPANY PROFILES

8.1.Aphios Corporation

8.1.1.Company overview
8.1.2.Key executive
8.1.3.Company snapshot
8.1.4.Product portfolio

8.2.Nanorh

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Product portfolio

8.3.Phosphorex, Inc.

8.3.1.Company overview
8.3.2.Key executive
8.3.3.Company snapshot
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments

8.4.CD Bioparticles

8.4.1.Company overview
8.4.2.Key executive
8.4.3.Company snapshot
8.4.4.Product portfolio

8.5.NanoSynthons LLC

8.5.1.Company overview
8.5.2.Key executive
8.5.3.Company snapshot
8.5.4.Product portfolio

8.6.Biopharma PEG

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Product portfolio

8.7.Creative PEGWorks

8.7.1.Company overview
8.7.2.Key executive
8.7.3.Company snapshot
8.7.4.Product portfolio

8.8.Nanoshel

8.8.1.Company overview
8.8.2.Key executive
8.8.3.Company snapshot
8.8.4.Product portfolio

8.9.Exelead

8.9.1.Company overview
8.9.2.Key executive
8.9.3.Company snapshot
8.9.4.Product portfolio

8.10.Nanovex Biotechnologies SL

8.10.1.Company overview
8.10.2.Key executive
8.10.3.Company snapshot
8.10.4.Product portfolio

LIST OF TABLES

TABLE 01.POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02.POLYMERIC NANOPARTICLES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03.POLYMERIC NANOPARTICLES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04.POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 05.POLYMERIC NANOPARTICLES MARKET, FOR PHARMACEUTICAL, BY REGION, 2020-2030 ($MILLION)
TABLE 06.POLYMERIC NANOPARTICLES MARKET, FOR ELECTRONICS, BY REGION, 2020-2030 ($MILLION)
TABLE 07.POLYMERIC NANOPARTICLES MARKET, FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 08.POLYMERIC NANOPARTICLES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 09.NORTH AMERICA POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 10.NORTH AMERICA POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 11.NORTH AMERICA POLYMERIC NANOPARTICLES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 12.U.S. POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 13.U.S. POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 14.CANADA POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 15.CANADA POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 16.MEXICO POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 17.MEXICO POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 18.EUROPE POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 19.EUROPE POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 20.EUROPE POLYMERIC NANOPARTICLES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 21.GERMANY POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 22.GERMANY POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 23.FRANCE POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 24.FRANCE POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 25.UK POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 26.UK POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 27.ITALY POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 28.ITALY POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 29.SPAIN POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 30.SPAIN POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 31.REST OF EUROPE POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 32.REST OF EUROPE POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 33.ASIA-PACIFIC POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 34.ASIA-PACIFIC POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 35.ASIA-PACIFIC POLYMERIC NANOPARTICLES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 36.CHINA POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 37.CHINA POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 38.JAPAN POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 39.JAPAN POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 40.INDIA POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 41.INDIA POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 42.SOUTH KOREA POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 43.SOUTH KOREA POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 44.AUSTRALIA POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 45.AUSTRALIA POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 46.REST OF ASIA-PACIFIC POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 47.REST OF ASIA-PACIFIC POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 48.LAMEA POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 49.LAMEA POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 50.LAMEA POLYMERIC NANOPARTICLES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 51.BRAZIL POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 52.BRAZIL POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 53.SAUDI ARABIA POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 54.SAUDI ARABIA POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 55.SOUTH AFRICA POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 56.SOUTH AFRICA POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 57.REST OF LAMEA POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 58.REST OF LAMEA POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 59.KEY PARTNERSHIP (2016-2020)
TABLE 60.APHIOS : KEY EXECUTIVES
TABLE 61.APHIOS : COMPANY SNAPSHOT
TABLE 62.APHIOS : PRODUCT PORTFOLIO
TABLE 63.NANORH: COMPANY SNAPSHOT
TABLE 64.NANORH: PRODUCT PORTFOLIO
TABLE 65.PHOSPHOREX: KEY EXECUTIVES
TABLE 66.PHOSPHOREX: COMPANY SNAPSHOT
TABLE 67.PHOSPHOREX: PRODUCT PORTFOLIO
TABLE 68.PHOSPHOREX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 69.CD BIOPARTICLES: KEY EXECUTIVES
TABLE 70.CD BIOPARTICLES: COMPANY SNAPSHOT
TABLE 71.CD BIOPARTICLES: PRODUCT PORTFOLIO
TABLE 72.NANOSYNTHONS: KEY EXECUTIVES
TABLE 73.NANOSYNTHONS: COMPANY SNAPSHOT
TABLE 74.NANOSYNTHONS: PRODUCT PORTFOLIO
TABLE 75.BIOPHARMA: COMPANY SNAPSHOT
TABLE 76.BIOPHARMA: PRODUCT PORTFOLIO
TABLE 77.CPW: KEY EXECUTIVES
TABLE 78.CPW: COMPANY SNAPSHOT
TABLE 79.CPW: PRODUCT PORTFOLIO
TABLE 80.NANOSHEL: KEY EXECUTIVES
TABLE 81.NANOSHEL: COMPANY SNAPSHOT
TABLE 82.NANOSHEL: PRODUCT PORTFOLIO
TABLE 83.EXELEAD: KEY EXECUTIVES
TABLE 84.EXELEAD: COMPANY SNAPSHOT
TABLE 85.EXELEAD: PRODUCT PORTFOLIO
TABLE 86.NANOVEX: KEY EXECUTIVES
TABLE 87.NANOVEX: COMPANY SNAPSHOT
TABLE 88.NANOVEX: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.KEY MARKET SEGMENTS
FIGURE 02.POLYMERIC NANOPARTICLES MARKET SNAPSHOT, BY SEGMENTATION, 2021–2030
FIGURE 03.POLYMERIC NANOPARTICLES MARKET SNAPSHOT, BY REGION, 2021–2030
FIGURE 04.TOP INVESTMENT POCKETS, BY COUNTRY
FIGURE 05.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.MODERATE THREAT OF SUBSTITUTES
FIGURE 08.LOW THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE INTENSITY OF RIVALRY
FIGURE 10.POLYMERIC NANOPARTICLES: MARKET DYNAMICS
FIGURE 11.POLYMERIC NANOPARTICLES MARKET, BY TYPE, 2020–2030 ($MILLION)
FIGURE 12.COMPARATIVE ANALYSIS OF POLYMERIC NANOCAPSULE MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF POLYMERIC NANOSPHERE MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.POLYMERIC NANOPARTICLES MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF POLYMERIC NANOPARTICLES MARKET, FOR PHARMACEUTICAL, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF POLYMERIC NANOPARTICLES MARKET, FOR ELECTRONICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF POLYMERIC NANOPARTICLES MARKET, FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.U.S. POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 19.CANADA POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 20.MEXICO POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 21.GERMANY POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 22.FRANCE POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 23.UK POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 24.ITALY POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 25.SPAIN POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 26.REST OF EUROPE POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 27.CHINA POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 28.JAPAN POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 29.INDIA POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 30.SOUTH KOREA POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 31.AUSTRALIA POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 32.REST OF ASIA-PACIFIC POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 33.BRAZIL POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 34.SAUDI ARABIA POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 35.SOUTH AFRICA POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 36.REST OF LAMEA POLYMERIC NANOPARTICLES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 37.MARKET PLAYER POSITIONING, 2020
FIGURE 38.PRODUCT MAPPING